US$ 28.51
spironolactone and glp 1 Finerenone vs Finerenone is more kidney–heart protective with fewer hormonal side effects less hyperkalemia risk—especially in diabetic CKD. Key Advantages of Finerenone 1) Stronger cardiorenal protection in diabetes ↓ progression Comparing the effect of spironolactone
Description
Wegovy is a GLP-1 receptor agonist for weight managementthey work through different mechanisms

GLP-1 RAs induced an early dip in eGFR, suggesting decreased intraglomerular pressure and decreased glomerular hyperfiltration, followed by slower eGFR loss in the overall population of GFR subgroups compared with placebo [13, 20], a feature shared with all currently known nephroprotective drugs ranging from reninangiotensin blockers to mineralocorticoid receptor antagonists to SGLT2is to tolvaptan [67]
Individualized Treatments for Hormonal Balance & Weight Loss Our care model is built around personalized, data-driven treatment strategies that address hormonal and metabolic health at the foundational level
It is a treatment

If a patient is not approved the clinical determination rests with the licensed provider
